Ocular Science/osrx
Biotech company operating a 503A drug compounding facility for eye products
Based in CA
AI Overview
With $65K in lobbying spend across 9 quarterly filings, Ocular Science/osrx is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $30K |
| 2021 | $35K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ocular Science/osrx disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
Outreach to Congress and Administration officials on matters related to FDA compounding issues and related matters
Outreach to Congress and Administration officials on FDA issues related to compound pharmacies and related matters
Outreach to Congress and Administration officials on FDA issues related to compound pharmacies and related matters.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.